Q2 2010 · —
Revenue$64.57M$64.57M no prior Q2 2009 on file+26.9% vs Q1 2010
Net Income$33.20M$33.20M no prior Q2 2009 on file+52.1% vs Q1 2010
EPS Diluted$0.71$0.71 no prior Q2 2009 on file+47.9% vs Q1 2010
Gross Profit$60,094,000—
Operating Income$10,582,000—
Margins · derived
Gross margin93.1%
Operating margin16.4%
Net margin51.4%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q2 2009 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Jazz Pharmaceuticals plc · CIK 1232524 · Engraved from SEC EDGAR